TP53 and in situ carcinoma: On the other hand, flat carcinoma in situ (CIS) often develops to invasive urothelial carcinoma [9, 10], in which allelic deletion of the TP53 (p53) and PTEN (tumor-suppressor) [11] and retinoblastoma gene (RB, negative cell cycle regulator) [12] is common.